TEMAZEPAM - AN OVERVIEW

Prevent coadministration with sensitive CYP3A substrates. If coadministration unavoidable, monitor for adverse reactions and reduce CYP3A substrate dose in accordance with product labeling.  The approximated history danger of big beginning defects and miscarriage for that indicated inhabitants is unidentified. All pregnancies Use a history chance